Aurobindo Pharma Limited
AUROPHARMA
Rang in aandelen
#2022
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
Aandeelprijs
$17.89
Laatst gesynchroniseerd: 2026-10-19
Marktkapitalisatie
$10.30B
Verandering (1 dag)
-2.27%
Verandering (1 jaar)
43.12%
Land
IN
Handel Aurobindo Pharma Limited (AUROPHARMA)
Categorie
Healthcare
EPS voor Aurobindo Pharma Limited (AUROPHARMA)
EPS per June 2026 TTM: $0.71
Volgens de laatste financiële rapporten en de aandelenkoers van Aurobindo Pharma Limited is de huidige EPS van het bedrijf (TTM) $0.71. Eind 2024 had het bedrijf een EPS van $0.65, een stijging ten opzichte van de EPS van 2023 die $0.40 bedroeg.
EPS-geschiedenis van Aurobindo Pharma Limited van 2004 tot 2026
EPS aan het einde van elk jaar
| Jaar | EPS | Wijzigen |
|---|---|---|
| 2026 (TTM) | $0.71 | 0.90% |
| 2025 | $0.70 | 7.68% |
| 2024 | $0.65 | 62.23% |
| 2023 | $0.40 | -32.77% |
| 2022 | $0.60 | -52.13% |
| 2021 | $1.24 | 92.96% |
| 2020 | $0.64 | 10.91% |
| 2019 | $0.58 | -8.50% |
| 2018 | $0.64 | 4.73% |
| 2017 | $0.61 | 15.90% |
| 2016 | $0.52 | 20.94% |
| 2015 | $0.43 | -3.95% |
| 2014 | $0.45 | 384.93% |
| 2013 | $0.09 | -322.25% |
| 2012 | $-0.04 | -119.03% |
| 2011 | $0.22 | -5.22% |
| 2010 | $0.23 | 529.89% |
| 2009 | $0.04 | -66.91% |
| 2008 | $0.11 | 27.82% |
| 2007 | $0.09 | 190.97% |
| 2006 | $0.03 | 1,893.33% |
| 2005 | 0.00 | -97.13% |
| 2004 | $0.05 | 0.00% |
EPS van vergelijkbare bedrijven of concurrenten
| Bedrijf | EPS | EPS-verschil | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -21.24% |
IN
|
